Can a targeted 'Missile' drug shrink Hard-to-Treat tumors?
Disease control
Recruiting now
This trial tests an experimental drug called MX006 in people with advanced solid tumors that carry a specific marker, B7-H3. MX006 is designed to deliver a toxic payload directly to cancer cells while sparing healthy tissue. The study has two parts: first, to find the safest dose…
Phase 1 • Sponsor: Myricx Pharma Limited • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC